443 related articles for article (PubMed ID: 35096486)
21. Radiomics feature analysis and model research for predicting histopathological subtypes of non-small cell lung cancer on CT images: A multi-dataset study.
Song F; Song X; Feng Y; Fan G; Sun Y; Zhang P; Li J; Liu F; Zhang G
Med Phys; 2023 Jul; 50(7):4351-4365. PubMed ID: 36682051
[TBL] [Abstract][Full Text] [Related]
22. Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Tankyevych O; Trousset F; Latappy C; Berraho M; Dutilh J; Tasu JP; Lamour C; Cheze Le Rest C
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497415
[TBL] [Abstract][Full Text] [Related]
23. Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer.
Han X; Wang M; Zheng Y; Wang N; Wu Y; Ding C; Jia X; Yang R; Geng M; Chen Z; Zhang S; Zhang K; Li Y; Liu J; Gu J; Liao Y; Fan J; Shi H
Eur Radiol; 2024 Apr; 34(4):2716-2726. PubMed ID: 37736804
[TBL] [Abstract][Full Text] [Related]
24. Histologic subtype classification of non-small cell lung cancer using PET/CT images.
Han Y; Ma Y; Wu Z; Zhang F; Zheng D; Liu X; Tao L; Liang Z; Yang Z; Li X; Huang J; Guo X
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):350-360. PubMed ID: 32776232
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Machine Learning-Based Model Using CT Radiomics for Predicting Immune Checkpoint Inhibitor-related Pneumonitis in Patients With NSCLC Receiving Anti-PD1 Immunotherapy: A Multicenter Retrospective CaseControl Study.
Zhang GY; Du XZ; Xu R; Chen T; Wu Y; Wu XJ; Liu S
Acad Radiol; 2024 May; 31(5):2128-2143. PubMed ID: 37977890
[TBL] [Abstract][Full Text] [Related]
26. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.
Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H
Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407
[TBL] [Abstract][Full Text] [Related]
27. Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics.
Yolchuyeva S; Ebrahimpour L; Tonneau M; Lamaze F; Orain M; Coulombe F; Malo J; Belkaid W; Routy B; Joubert P; Manem VS
J Transl Med; 2024 Jan; 22(1):42. PubMed ID: 38200511
[TBL] [Abstract][Full Text] [Related]
28. A combined model using pre-treatment CT radiomics and clinicopathological features of non-small cell lung cancer to predict major pathological responses after neoadjuvant chemoimmunotherapy.
Wang F; Yang H; Chen W; Ruan L; Jiang T; Cheng L; Jiang H; Fang M
Curr Probl Cancer; 2024 Jun; 50():101098. PubMed ID: 38704949
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive classification of non-small cell lung cancer: a comparison between random forest models utilising radiomic and semantic features.
Bashir U; Kawa B; Siddique M; Mak SM; Nair A; Mclean E; Bille A; Goh V; Cook G
Br J Radiol; 2019 Jul; 92(1099):20190159. PubMed ID: 31166787
[TBL] [Abstract][Full Text] [Related]
30. Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients.
Farina B; Guerra ADR; Bermejo-Peláez D; Miras CP; Peral AA; Madueño GG; Jaime JC; Vilalta-Lacarra A; Pérez JR; Muñoz-Barrutia A; Peces-Barba GR; Maceiras LS; Gil-Bazo I; Gómez MD; Ledesma-Carbayo MJ
J Transl Med; 2023 Mar; 21(1):174. PubMed ID: 36872371
[TBL] [Abstract][Full Text] [Related]
31. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
Front Immunol; 2022; 13():859323. PubMed ID: 35572597
[TBL] [Abstract][Full Text] [Related]
32. Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach.
Zhao J; He Y; Yang X; Tian P; Zeng L; Huang K; Zhao J; Zhou J; Zhu Y; Wang Q; Chen M; Li W; Gao Y; Zhang Y; Xia Y
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730276
[TBL] [Abstract][Full Text] [Related]
33. The CT delta-radiomics based machine learning approach in evaluating multiple primary lung adenocarcinoma.
Ma Y; Li J; Xu X; Zhang Y; Lin Y
BMC Cancer; 2022 Sep; 22(1):949. PubMed ID: 36057553
[TBL] [Abstract][Full Text] [Related]
34. Radiomics Analysis of Computed Tomography helps predict poor prognostic outcome in COVID-19.
Wu Q; Wang S; Li L; Wu Q; Qian W; Hu Y; Li L; Zhou X; Ma H; Li H; Wang M; Qiu X; Zha Y; Tian J
Theranostics; 2020; 10(16):7231-7244. PubMed ID: 32641989
[No Abstract] [Full Text] [Related]
35. Performance of radiomics models for survival prediction in non-small-cell lung cancer: influence of CT slice thickness.
Park S; Lee SM; Kim S; Choi S; Kim W; Do KH; Seo JB
Eur Radiol; 2021 May; 31(5):2856-2865. PubMed ID: 33128185
[TBL] [Abstract][Full Text] [Related]
36. Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer.
Zhu X; Dong D; Chen Z; Fang M; Zhang L; Song J; Yu D; Zang Y; Liu Z; Shi J; Tian J
Eur Radiol; 2018 Jul; 28(7):2772-2778. PubMed ID: 29450713
[TBL] [Abstract][Full Text] [Related]
37. Application of radiomics based on chest CT-enhanced dual-phase imaging in the immunotherapy of non-small cell lung cancer.
Ma ZP; Li XL; Gao K; Zhang TL; Wang HD; Zhao YX
J Xray Sci Technol; 2023; 31(6):1333-1340. PubMed ID: 37840466
[TBL] [Abstract][Full Text] [Related]
38. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
[TBL] [Abstract][Full Text] [Related]
39. A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics.
Wang X; Duan H; Li X; Ye X; Huang G; Nie S
Phys Med Biol; 2020 Feb; 65(4):045006. PubMed ID: 31962301
[TBL] [Abstract][Full Text] [Related]
40. Prognostic analysis and risk stratification of lung adenocarcinoma undergoing EGFR-TKI therapy with time-serial CT-based radiomics signature.
Zhang X; Lu B; Yang X; Lan D; Lin S; Zhou Z; Li K; Deng D; Peng P; Zeng Z; Long L
Eur Radiol; 2023 Feb; 33(2):825-835. PubMed ID: 36166088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
